Arcus Biosciences Alternatives & Competitors
12 companies similar to Arcus Biosciences — Global, biopharmaceutical company at the forefront of designing precision combin...
Companies similar to Arcus Biosciences
Compugen
A clinical-stage cancer immunotherapy company and a pioneer in computational target discov...
Israel
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
Mosaic TX
Resolving cancer's complexity through the power of targeted drug combinations
United Kingdom
Orum Therapeutics
A public biotechnology company pioneering a novel class of protein degraders.
Lexington, United States
Track all Arcus Biosciences competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Probmet Therapeutics
An oncology therapeutics company developing new targeted treatments for breast cancer brai...
Denmark
FogPharma
Until everything is druggable.
Cambridge, United States
Synnovation Therapeutics
A precision oncology company focused on small molecule therapies optimized to target key d...
Wilmington, United States
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Cambridge, United States
Biocon
Transforming Healthcare. Transforming Lives.
Bengaluru, India
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...
London, United Kingdom
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
About Arcus Biosciences
Arcus Biosciences, founded in 2015, stands at the forefront of the biopharmaceutical industry, specializing in the creation of precision combination medicines aimed at extending the lives of cancer patients. As a clinical-stage global entity headquartered in the United States, the company is strategically positioned in...
Designing and developing combination therapies, Conducting clinical trials for cancer treatments, Developing small molecules and antibodies, Collaborations with pharmaceutical companies for drug development
Cancer patients, Healthcare providers, Research institutions, Pharmaceutical companies
Biopharmaceutical, Oncology, Precision Medicine, Immunotherapy, Combination Therapies, Cancer Treatment, Clinical-stage, Novel Therapies, Immunology, Drug Development, Adenosine Receptor Antagonist, Small-molecule Inhibitor, Monoclonal Antibodies, Hematological Malignancies, Clinical Trials
B2B, B2B2C
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Arcus Biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Arcus Biosciences on 22 Jun 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
